Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,846 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Whole-body insulin sensitivity index is a highly specific predictive marker for virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients with genotype 1b and high viral load.
Mizuta T, Kawaguchi Y, Eguchi Y, Takahashi H, Ario K, Akiyama T, Oza N, Otsuka T, Kuwashiro T, Yoshimura T, Hisatomi A, Ozaki I. Mizuta T, et al. Among authors: otsuka t. Dig Dis Sci. 2010 Jan;55(1):183-9. doi: 10.1007/s10620-008-0691-2. Epub 2009 Jan 30. Dig Dis Sci. 2010. PMID: 19184426
Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J).
Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M, Araki N, Tanaka K, Yamaguchi M, Matsuda Y, Ide Y, Otsuka T, Ozaki I, Ono N, Eguchi T, Anzai K; Japan Study Group for NAFLD (JSG-NAFLD). Eguchi Y, et al. Among authors: otsuka t. Hepatol Res. 2015 Mar;45(3):269-78. doi: 10.1111/hepr.12351. Epub 2014 May 28. Hepatol Res. 2015. PMID: 24796231
Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1b.
Kawaguchi Y, Iwane S, Kumagai T, Yanagita K, Yasutake T, Ide Y, Otsuka T, Eguchi Y, Ozaki I, Akiyama T, Kawazoe S, Mizuta T. Kawaguchi Y, et al. Among authors: otsuka t. Intern Med. 2015;54(20):2551-60. doi: 10.2169/internalmedicine.54.4817. Epub 2015 Oct 15. Intern Med. 2015. PMID: 26466688 Free article.
Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial.
Iwane S, Mizuta T, Kawaguchi Y, Takahashi H, Oza N, Oeda S, Nakashita S, Kuwashiro T, Otsuka T, Kawazoe S, Eguchi Y, Anzai K, Ozaki I, Fujimoto K. Iwane S, et al. Among authors: otsuka t. Intern Med. 2015;54(24):3113-9. doi: 10.2169/internalmedicine.54.5574. Epub 2015 Dec 15. Intern Med. 2015. PMID: 26666596 Free article. Clinical Trial.
1,846 results